CRISPR Therapeutics AG - FORM 10-K - EX-21.1 - March 8, 2018

Attached files

file filename
EX-10.20.6 - EX-10.20.6 - CRISPR Therapeutics AGcrsp-ex10206_548.htm
EX-32.1 - EX-32.1 - CRISPR Therapeutics AGcrsp-ex321_552.htm
EX-31.2 - EX-31.2 - CRISPR Therapeutics AGcrsp-ex312_551.htm
EX-31.1 - EX-31.1 - CRISPR Therapeutics AGcrsp-ex311_550.htm
EX-23.2 - EX-23.2 - CRISPR Therapeutics AGcrsp-ex232_614.htm
EX-23.1 - EX-23.1 - CRISPR Therapeutics AGcrsp-ex231_613.htm
EX-10.26 - EX-10.26 - CRISPR Therapeutics AGcrsp-ex1026_549.htm
EX-10.20.5 - EX-10.20.5 - CRISPR Therapeutics AGcrsp-ex10205_547.htm
EX-10.20.4 - EX-10.20.4 - CRISPR Therapeutics AGcrsp-ex10204_546.htm
EX-10.20.3 - EX-10.20.3 - CRISPR Therapeutics AGcrsp-ex10203_545.htm
EX-10.20.2 - EX-10.20.2 - CRISPR Therapeutics AGcrsp-ex10202_544.htm
EX-10.20.1 - EX-10.20.1 - CRISPR Therapeutics AGcrsp-ex10201_543.htm
EX-10.20 - EX-10.20 - CRISPR Therapeutics AGcrsp-ex1020_542.htm
EX-10.17 - EX-10.17 - CRISPR Therapeutics AGcrsp-ex1017_541.htm
EX-10.16 - EX-10.16 - CRISPR Therapeutics AGcrsp-ex1016_540.htm
EX-10.13 - EX-10.13 - CRISPR Therapeutics AGcrsp-ex1013_539.htm
10-K - 10-K - CRISPR Therapeutics AGcrsp-10k_20171231.htm

Exhibit 21.1

Subsidiaries of the Registrant

 

Name of Subsidiary

 

Jurisdiction of Incorporation or Organization

CRISPR Therapeutics, Inc.

 

Delaware

CRISPR Therapeutics Ltd.

 

United Kingdom

TRACR Hematology Ltd

 

United Kingdom

 

CRISPR Therapeutics AG Reports